Elevance Health, Inc. (0HG8.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 78.69B |
| Enterprise Value | 101.91B |
| P/E Ratio | 18.72 |
| PEG Ratio | -4.16 |
| Price/Sales Ratio | 0.45 |
| Price/Book Ratio | 2.05 |
| Enterprise/Revenue | 0.56 |
| Enterprise/EBITDA | 14.01 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.04 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 199.13B |
| Revenue/Share | 922.96 |
| Gross Profit | 50.9B |
| EBITDA | 9.66B |
| Net Income | 5.66B |
| Diluted EPS | 25.21 |
Balance Sheet
| Total Cash | 10.23B |
| Total Cash/Share | 172.16 |
| Total Debt | 31.04B |
| Total Debt/Equity | 0.69 |
| Current Ratio | 2.05 |
| Book Value Per Share | 206.62 |
Price History
| 52-Week Change | 33.6 |
| 52-Week High | 516.42 |
| 52-Week Low | 410.31 |
| Moving Average 50 Days | 493.4 |
| Moving Average 200 Days | 466.52 |
Statistics
| Average Volume | 8,372 |
| Shares Outstanding | 216.87M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 6.87 |
| Trailing Annual Dividend Yield | 1.63 |
| Payout Ratio | 0.3 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
